Development and Validation of the Polish Version of the Female Sexual Function Index in the Polish Population of Females

Authors

  • Krzysztof Nowosielski MD, PhD,

    Corresponding author
    1. Department of Gynecology and Obstetrics, Specialist Teaching Hospital in Tychy, Tychy, Poland
    2. Department of Health Science, Medical Collage in Sosnowiec, Sosnowiec, Poland
    Search for more papers by this author
  • Beata Wróbel MD, PhD,

    1. Center for Sexual Medicine, Dąbrowa Górnicza, Poland
    Search for more papers by this author
  • Urszula Sioma-Markowska MSc, PhD,

    1. Department of Gynecology and Obstetrics, The School of Health Care, Medical University of Silesia, Katowice, Tychy, Poland
    Search for more papers by this author
  • Ryszard Poręba MD

    1. Department of Gynecology and Obstetrics, Specialist Teaching Hospital in Tychy, Tychy, Poland
    2. Department of Gynecology and Obstetrics, The School of Health Care, Medical University of Silesia, Katowice, Tychy, Poland
    Search for more papers by this author

Krzysztof Nowosielski, MD, PhD, Department of Gynecology and Obstetrics, Specialist Teaching Hospital in Tychy, ul. Edukacji 102, 43- 100 Tychy, Poland. Tel: +48-502-027-943; Fax: +48 3221934 04; E-mail: krzysnowosilcow@yahoo.com

ABSTRACT

Introduction.  Unlike male sexual function, which is relatively easy to assess, female sexual function is still a diagnostic challenge. Although numerous new measurements for female sexual dysfunction (FSD) have recently been developed, the Female Sexual Function Index (FSFI) remains the gold standard for screening. It has been validated in more than 30 countries. The FSFI has been used in several studies conducted in Poland, but it has never been standardized for Polish women.

Aim.  The aim of this study was to develop a Polish version of the FSFI (PL-FSFI).

Materials and Methods.  In total, 189 women aged 18–55 years were included in the study. Eighty-five were diagnosed with FSD as per the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM IV-TR) criteria; 104 women did not have FSD. All subjects completed the PL-FSFI at baseline (day 0), day 7, and day 28.

Main Outcome Measures.  Test–retest reliability was determined by Pearson's product–moment correlations. Reliability was tested using Cronbach's α coefficient. Construct validity was evaluated by principal component analysis using varimax rotation and factor analysis. Discriminant validity was assessed with between-groups analysis of variance.

Results.  All domains of the PL-FSFI demonstrated satisfactory internal consistencies, with Cronbach's α value of >0.70 for the entire sample. The test–retest reliability demonstrated good-to-excellent agreement between the assessment points. Based on principal component analysis, a 5-factor model was established that explained 83.62% of the total variance. Domain intercorrelations of the PL-FSFI ranged from 0.37–0.77. The optimal PL-FSFI cutoff score was 27.50, with 87.1% sensitivity and 83.1% specificity.

Conclusion.  The PL-FSFI is a reliable questionnaire with good psychometric and discriminative validity. Therefore, it can be used as a tool for preliminary screening for FSD among Polish women. Nowosielski K, Wróbel B, Sioma-Markowska U, and Poręba R. Development and validation of the Polish version of the Female Sexual Function Index in the Polish Population of Females. J Sex Med **;**:**–**.

Ancillary